Latest News
Latest News
Why Are We Undertreating So Many Pulmonary Embolisms?
Based on deidentified data, less than half of one percent of patients who experience a PE receive advanced therapy.
Commentary
Who Benefits From Omega-3/Fish Oil Supplements?
Supplements will not replace healthy diet, but patients who do not eat fish and have CVD risks could benefit.
Latest News
Study Finds Mace Risk Remains High in Patients with Psoriasis, Dyslipidemia
Current guidelines recommend statins “for patients with psoriasis who have additional risk-enhancing factors, similar to recommendations made for...
Latest News
Arterial Stiffness May Predict Risk for Glaucoma
Incident rate of glaucoma increased across all levels of arterial stiffness evaluated in new study.
Latest News
Progestin-Only IUDs Linked to 22% Lower Ischemic Stroke Risk
The IUDs had also been previously associated with lower risk for thromboembolism.
Commentary
Calcium and CV Risk: Are Supplements and Vitamin D to Blame?
Tricia Ward interviews Dr. Matthew Budoff about the link between calcium intake and higher risk for CV events. Is it the link seen for dietary...
Latest News
Another Reason to Control Lp(a): To Protect the Kidneys Too
Having increased Lp(a) levels on their own is not sufficient to trigger chronic kidney disease, but another event may set off a bidirectional...
Conference Coverage
Colchicine: A New Tool for Ischemic Stroke, CVD Event Recurrence?
CONVINCE trial results support the hypothesis that long-term anti-inflammatory therapy with colchicine may reduce recurrent stroke and...
Latest News
Counting Steps or Watching the Clock for a Longer Life?
The new findings provide a basis for using step counts to set physical activity goals — both in individual patient counseling and in formal...
Latest News
New Drug Offers Hope for CPAP-Free Nights for Sleep Apnea
Pill aimed at treating sleep apnea in phase 3 trials and shows improvement in fatigue.
Latest News
Gene Tests Could Predict if a Drug Will Work for a Patient
Pharmacogenetics could help physicians determine which patients would and would not benefit from medications.